In vivo flow cytometry system and method
The present invention provides methods and systems for performing in vivo flow cytometry. In one embodiments, selected circulating cells of interest of a subject are labeled with fluorescent probe molecules. The labeled cells are irradiated in vivo so as to excite the fluorescent probes, and the radiation emitted by the excited probes is detected, preferably confocally. The detected radiation is then analyzed to derive desired information, such as relative cell count, of the cells of interest.
1. A method of performing in vivo cytometry, comprising
labeling one or more cells of a subject with one or more fluorescent probe molecules while said cells circulate in said subject's vasculature said cells being of a selected type,
illuminating said labeled cells in vivo with radiation having one or more wavelengths suitable for exciting said fluorescent probe molecules,
detecting fluorescence radiation emitted by said excited fluorescent probe molecules in response to said excitation, and
analyzing said detected fluorescence radiation so as to count labeled circulating cells from which fluorescence is detected.
2. The method of claim 1 , wherein said labeling step comprises introducing said probe molecules into the subject's circulatory system.
3. The method of claim 1 , wherein said fluorescent probe molecules label said cells by coupling to one or more selected cell surface molecules.
4. The method of claim 3 , wherein said fluorescent probe molecules comprise an antibody capable of binding to a surface antigen of said cell type.
5. The method of claim 1 , wherein said fluorescent probe molecules label said cells coupling to a membrane protein of said cells.
6. The method of claim 5 , wherein said cell type can be any of leukocytes, tumor cells, and stem cells.
7. The method of claim 1 , wherein said illuminating and detecting steps are performed confocally.
8. The method of claim 1 , further comprising the step of comparing said measured cell count with a previously measured cell count of said cells of said selected type to determine a change in cell count of said cell type over a temporal interval.
9. The method of claim 8 , wherein said change in cell count of said cell type can be indicative of progress of a treatment protocol applied to said subject.
10. The method of claim 1 , wherein said illuminating step comprises utilizing radiation having one or more wavelength components in a range of about 400 nm to about 1000 nm.
11. The method of claim 1 , wherein said illuminating step comprises exposing said labeled cells to radiation from a continuous wave (CW) source for a selected duration to excite said fluorescent probes.
12. The method of claim 1 , wherein said analyzing step comprises identifying fluorescent intensity peaks in fluorescent radiation emitted by said fluorescent probe molecules in response to said excitation.
13. The method of claim 12 , wherein said analyzing step comprises measuring widths of said identified intensity peaks.
14. The method of claim 13 , further comprising analyzing said widths to derive flow characteristics of circulating cells of said cell type.
15. The method of claim 14 , wherein said selected flow characteristic comprises a flow velocity.
16. The method of claim 13 , wherein said analyzing step further comprises distinguishing between single fluorescent peaks and partially overlapping multiple fluorescent peaks.
17. The method of claim 13 , wherein said analyzing step further comprises identifying detection time of each identified fluorescent peaks relative to that of the others.
18. The method of claim 12 , further comprising determining an average noise level associated with said detecting step.
19. The method of claim 18 , wherein said step identifying peaks comprises selecting a peak as a fluorescent peak if it exhibits a height higher by a selected factor than said average noise level.
20. The method of claim 1 , wherein said derived information provides an absolute cell count of said circulating cell type.
21. The method of claim 20 , wherein said absolute cell count can be indicative of any of presence of a disease and progress of a treatment protocol.
22. The method of claim 21 , further comprising analyzing said fluorescence peak widths to derive flow characteristics of circulating cells of said cell type.
23. The method of claim 1 , wherein said analyzing step further comprises filtering high frequency noise present in said detected fluorescence radiation.
24. A method of performing in vivo flow cytometry, comprising:
labeling ex vivo a plurality of cells of a selected type extracted from a subject with fluorescent probe molecules of a type capable of coupling to said cells,
introducing said labeled cells into the subject's circulatory system,
illuminating said labeled cells in vivo with radiation having one or more wavelengths suitable for exciting said fluorescent probe molecules,
a detecting fluorescence radiation emitted by said excited flourescent probe molecules in response to said excitation, and
analyzing said detected fluorescence radiation so as to count labeled circulating cells from which fluorescence is detected.
25. The method of claim 24 , wherein said step of detecting fluorescence radiation comprises confocally detecting said fluorescence radiation.
26. A method of performing cytometry, comprising
labeling one or more cells of a subject with one or more fluorescent probe molecules a while said cells circulate in the subject's vasculature said cells being of a selected type,
illuminating a portion of blood circulating through a vessel of the subject so as to excite one or more fluorescent probe molecules of one or more of said labeled cells,
detecting fluorescence radiation emitted by one or more of said excited fluorescent probe molecules, and
analyzing said detected fluorescence radiation so as to determine a cell count of labeled circulating cells of said type.